Objectives: 1. Explore a new treatment protocol
2. Learn how to practically treat patients with facial photoaging who deserve more than a simple photorejuvenation but are not willing to accept a long downtime procedure
3. Understand how 2 different technologies can be synergistic if used sequentially
Introduction: The constant research to obtain an aesthetic improvement of the face with a rapid recovery and a minimum risk is at the basis of a new treatment protocol. Efficacy and safety of a new sequential (same session) use of IPL and microneedle radiofrequency and galvanic energy for facial rejuvenation have been evaluated.
Materials / method: 212 patients with mild to moderate facial solar elastosis have been enrolled since 2018. The new therapeutic protocol consists of 4 treatment sessions at 30-40 days interval. A full face OPT - IPL photorejuvenation procedure is immediatelly followed by a 3 pass hybrid energy MRF procedure The degree of photoaging and the efficacy of treatment were evaluated using a modified Dover's scale (5 point scale for global score, fine lines, mottled pigmentation, sallow complexion, tactile roughness and coarse wrinkles). The follow-up was at 6 months after the end of the last treatment session.
Results: All the variables of the modified Dover’s scale showed a statistically significant improvement in the majority (> 75%) of patients and only minor adverse events have been recorded.
Conclusion: It is hypothesized that the observed improvement could be attributed to the synergistic effect of the 2 technologies used sequentially. The IPL treatment, by increasing the tissue temperature and increasing the water content of tissues, could allow a greater and deeper diffusion of the radiofrequency explaining, consequently, the results that can be observed on collagen production
Disclosures
Did you receive any funding to support your research for this TOPIC?
No
Were you provided with any honoraria, payment or other compensation for your work on this study?
No
Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No
Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No
This work was not supported by any direct or non direct funding. It is under the author's own responsability